Nyxoid is a medicine used for emergency treatment in case of known or suspected overdose of opioid drugs (such as heroin or morphine). Signs of overdose include pinpoint pupils, abnormally slow and irregular breathing, severe sleepiness and unresponsiveness to touch or loud noises.

Job number: UK-NYX-2100001 | Date of preparation: October 2021. We use cookies to collect your browsing data to analyse traffic, fix bugs and make our site better. You can consent or …

2024年5月10日 · Nyxoid is intended for immediate administration as emergency therapy for known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression in both non-medical and healthcare settings. Nyxoid is indicated in adults and adolescents aged 14 years and over. Nyxoid is not a substitute for emergency medical care.

Nyxoid is intended for immediate administration as emergency therapy for known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression in both non-medical and healthcare settings.

What is Nyxoid? How does Nyxoid work? Nyxoid contains naloxone, which temporarily reverses the effect of opioid drugs. Naloxone works by displacing opioid drug molecules from their receptors in the brain and body. There is also a Quick Start Guide on the back of the Nyxoid container. This leaflet is designed for patients,

2023年7月26日 · Health workers should provide the consumer information sheet – Nyxoid® to clients receiving Nyxoid®. This information is specifically for the opioid overdose response and take home naloxone intervention.

NYXOID ® nasal spray is a single-dose nasal spray, containing naloxone. It is used as part of the emergency treatment of an overdose, or possible overdose of heroin or other opioid drugs. 1 Opioid drugs might include medications such as:

Nyxoid is a nasal spray available in single-dose containers (1.8 mg). The recommended dose is one spray into one nostril given immediately on suspecting an opioid overdose and while awaiting emergency services; if the first dose does not have an effect, a second dose should be given after 2–3 minutes in the other nostril.

2018年3月12日 · Concentrated naloxone 1.8 mg nasal spray (Nyxoid ®) is approved for the emergency treatment of opioid overdose in adults and adolescents aged ≥ 14 years in non-medical and healthcare settings. It is well tolerated, but may lead to opioid withdrawal syndrome in opioid-dependent individuals.

Nyxoid is intended as part of the emergency treatment for known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression in: the home or other non-medical setting; a health facility setting; For this reason, Nyxoid should be carried by persons at risk of, or likely to witness such events.